April 27, 2020

Italfarmaco Provides Update on Advanced-Stage Clinical Development Program with Givinostat in Duchenne

Good news from Italfarmaco! As discussed on our webinar last week, an Independent Data Monitoring Committee (IDMC) has recommended the continuation of their Phase 3 Givinostat trial, determining that the trial is not futile. They…

Learn More

April 27, 2020

WATCH: Italfarmaco Provides Givinostat Update

Webinar Recording: Italfarmaco Provides Givinostat Update On April 22, 2020, Italfarmaco joined PPMD for a webinar to update the community about Italfarmaco’s development of Givinostat and the recent results of the futility analysis of the…

Learn More

March 27, 2020

Italfarmaco Shares Community Update on Givinostat Trials & COVID-19

Italfarmaco has shared an update with the community regarding givinostat clinical trials and COVID-19. Read the update from Italfarmaco Dear Duchenne Community, ITALFARMACO team would like to take this opportunity to inform you that we…

Learn More

January 8, 2020

Italfarmaco Shares Winter 2020 Newsletter

Italfarmaco has shared the Winter 2020 issue of their newsletter, including updates on the Givinostat Development Program. Click here to download.

Learn More

September 23, 2019

Italfarmaco Shares Fall 2019 Newsletter

Italfarmaco has shared the Fall 2019 issue of their newsletter, including updates on the Givinostat Development Program. Click here to download.

Learn More

April 3, 2019

WATCH: Italfarmaco Provides Givinostat Update – Webinar Recording

On Wednesday, March 27, 2019, Italfarmaco joined Parent Project Muscular Dystrophy for a webinar to update the community about Italfarmaco’s development of Givinostat and currently enrolling Phase 3 confirmatory study in Duchenne muscular dystrophy. If…

Learn More